← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2019Last known activity
Jan 6, 2020
Defunct as of Dec 31, 2025
Timeline
2000s
- Jan 1, 2000
Mapreg— Founded
2020s
- Dec 31, 2025
Mapreg— Defunct
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT04157114CollaboratorPhase 2Jan 6, 2020
- NCT03870776Lead sponsorPhase 2Apr 1, 2019
Details
- Founded
- Kremlin-Bicetre, FR Jan 1, 2000
- Last known activity
- Jan 6, 2020